Brief: Enorama Pharma Q2 Operating Loss Widens To SEK 10.4 Million

Enorama Pharma AB

17/08/2022 07:43

Aug 17 (Reuters) - Enorama Pharma AB  ERMA.ST :
    * H1 OPERATING LOSS SEK 21.1 MILLION VERSUS LOSS SEK 11.2
MILLION
YEAR AGO
    * H1 LOSS BEFORE TAX SEK 21.4 MILLION VERSUS LOSS SEK 11.4
MILLION
YEAR AGO
    * Q2 OPERATING LOSS SEK 10.4 MILLION VERSUS SEK 5.3 MILLION
YEAR
AGO
    * Q2 NET SALES SEK 2.9 MILLION VERSUS SEK 3.2 MILLION YEAR
AGO

Source text for Eikon:  ID:nWkr8RgStL 
Further company coverage:  ERMA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))